Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer
Abstract Background The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy variants and to correlate mutational load to clinical data. Methods Circulating cell-free DNA...
Main Authors: | Alvida Qvick, Bianca Stenmark, Jessica Carlsson, Johan Isaksson, Christina Karlsson, Gisela Helenius |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Molecular Medicine |
Online Access: | https://doi.org/10.1186/s10020-021-00331-1 |
Similar Items
-
Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy
by: Kezhong Chen, et al.
Published: (2021-01-01) -
Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
by: Florence de Fraipont, et al.
Published: (2019-05-01) -
Liquid biopsy in lung cancer-hope or hype?
by: Anuradha Choughule, et al.
Published: (2019-01-01) -
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
by: Milena Matuszczak, et al.
Published: (2021-07-01) -
A prospection observation study on liquid biopsy in cancer diagnosis and prognosis
by: Yuhsiang Cheng, et al.
Published: (2019)